| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.16▼ | 4.23▼ | 4.20▼ | 5.19▼ | 6.70▼ |
| MA10 | 4.18▼ | 4.17▼ | 4.26▼ | 6.46▼ | 7.43▼ |
| MA20 | 4.21▼ | 4.32▼ | 4.60▼ | 7.15▼ | 6.66▼ |
| MA50 | 4.20▼ | 4.76▼ | 5.70▼ | 7.71▼ | 5.20▼ |
| MA100 | 4.26▼ | 5.91▼ | 7.01▼ | 6.72▼ | 6.05▼ |
| MA200 | 4.59▼ | 7.04▼ | 7.50▼ | 5.12▼ | 4.22▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.011▼ | 0.032▲ | 0.032▲ | -0.438▼ | -0.295▼ |
| RSI | 38.220▼ | 35.759▼ | 34.050▼ | 28.748▼ | 39.305▼ |
| STOCH | 28.350 | 71.594 | 33.271 | 13.350▼ | 37.669 |
| WILL %R | -80.000▼ | -60.274 | -74.892 | -94.340▼ | -94.698▼ |
| CCI | -153.088▼ | -31.245 | -66.853 | -139.004▼ | -255.777▼ |
|
Tuesday, November 10, 2026 11:15 AM
Exagen (NASDAQ:XGN) reported third-quarter revenue of $18.4 million, up 7% from a year earlier, as higher test volume and pricing helped the autoimmune diagnostics company post what management ...
|
|
Monday, November 09, 2026 11:30 PM
Third Quarter Revenue Grew 7% to $18.4 Million Year-to-Date Revenue Grew 11%, Net Loss Reduced by 12% and Adjusted EBITDA Loss Improved by Over ...
|
|
Tuesday, August 04, 2026 08:27 AM
Exagen (NASDAQ:XGN) delivered record quarterly revenue, narrowed losses, improved adjusted EBITDA, and increased its full-year revenue outlook as demand for its autoimmune testing portfolio continued ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 4.37 | 4.382 | 3.845 | 4.13 | 3,356,139 |
| 12/11/26 | 5.02 | 5.10 | 4.39 | 4.41 | 1,368,577 |
| 11/11/26 | 5.59 | 5.65 | 4.69 | 5.035 | 1,203,011 |
| 10/11/26 | 6.25 | 6.30 | 4.605 | 5.26 | 2,191,100 |
| 09/11/26 | 5.90 | 7.19 | 5.90 | 7.10 | 671,695 |
| 06/11/26 | 7.61 | 7.90 | 5.69 | 5.81 | 1,194,981 |
| 05/11/26 | 8.43 | 8.4826 | 7.46 | 7.60 | 411,365 |
| 04/11/26 | 8.52 | 8.67 | 8.31 | 8.51 | 131,621 |
| 03/11/26 | 8.39 | 8.705 | 8.30 | 8.34 | 96,679 |
| 02/11/26 | 8.59 | 8.67 | 8.21 | 8.39 | 243,094 |
|
|
||||
|
|
||||
|
|